227 related articles for article (PubMed ID: 37293175)
1. DDX3 suppresses hepatocellular carcinoma progression through modulating the secretion and composition of exosome.
Su YY; Chao CH; Hsu HY; Li HK; Wang YL; Wu Lee YH; Mai RT
Am J Cancer Res; 2023; 13(5):1744-1765. PubMed ID: 37293175
[TBL] [Abstract][Full Text] [Related]
2. DDX3 Represses Stemness by Epigenetically Modulating Tumor-suppressive miRNAs in Hepatocellular Carcinoma.
Li HK; Mai RT; Huang HD; Chou CH; Chang YA; Chang YW; You LR; Chen CM; Lee YH
Sci Rep; 2016 Jun; 6():28637. PubMed ID: 27344963
[TBL] [Abstract][Full Text] [Related]
3. Improved Aitongxiao prescription (I-ATXP) induces apoptosis, cell cycle arrest and blocks exosomes release in hepatocellular carcinoma (HCC) cells.
Huang MB; Gao Z; Xia M; Zhao X; Fan X; Lin S; Zhang L; Huang L; Wei A; Zhou H; Wu JY; Roth WW; Bond VC; Leng J
Int J Physiol Pathophysiol Pharmacol; 2022; 14(2):90-113. PubMed ID: 35619665
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma.
Yang L; Peng X; Li Y; Zhang X; Ma Y; Wu C; Fan Q; Wei S; Li H; Liu J
Mol Cancer; 2019 Apr; 18(1):78. PubMed ID: 30943982
[TBL] [Abstract][Full Text] [Related]
5. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.
Chang PC; Chi CW; Chau GY; Li FY; Tsai YH; Wu JC; Wu Lee YH
Oncogene; 2006 Mar; 25(14):1991-2003. PubMed ID: 16301996
[TBL] [Abstract][Full Text] [Related]
6. Exosome-transmitted circ_002136 promotes hepatocellular carcinoma progression by miR-19a-3p/RAB1A pathway.
Yuan P; Song J; Wang F; Chen B
BMC Cancer; 2022 Dec; 22(1):1284. PubMed ID: 36476239
[TBL] [Abstract][Full Text] [Related]
7. Exosomes secreted by M2 macrophages promote cancer stemness of hepatocellular carcinoma via the miR-27a-3p/TXNIP pathways.
Li W; Xin X; Li X; Geng J; Sun Y
Int Immunopharmacol; 2021 Dec; 101(Pt A):107585. PubMed ID: 34601333
[TBL] [Abstract][Full Text] [Related]
8. Vps4A functions as a tumor suppressor by regulating the secretion and uptake of exosomal microRNAs in human hepatoma cells.
Wei JX; Lv LH; Wan YL; Cao Y; Li GL; Lin HM; Zhou R; Shang CZ; Cao J; He H; Han QF; Liu PQ; Zhou G; Min J
Hepatology; 2015 Apr; 61(4):1284-94. PubMed ID: 25503676
[TBL] [Abstract][Full Text] [Related]
9. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
Chen L; Guo P; He Y; Chen Z; Chen L; Luo Y; Qi L; Liu Y; Wu Q; Cui Y; Fang F; Zhang X; Song T; Guo H
Cell Death Dis; 2018 May; 9(5):513. PubMed ID: 29725020
[TBL] [Abstract][Full Text] [Related]
10. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10.
Xu Y; Lai Y; Cao L; Li Y; Chen G; Chen L; Weng H; Chen T; Wang L; Ye Y
RNA Biol; 2021 Oct; 18(10):1408-1423. PubMed ID: 33206588
[TBL] [Abstract][Full Text] [Related]
11. Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma.
Hu Z; Chen G; Zhao Y; Gao H; Li L; Yin Y; Jiang J; Wang L; Mang Y; Gao Y; Zhang S; Ran J; Li L
Mol Cancer; 2023 Mar; 22(1):55. PubMed ID: 36932387
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of ST6Gal-I expression in human hepatocellular carcinoma cells inhibits their exosome-mediated proliferation- and migration-promoting effects.
Wang L; Chen X; Wang L; Wang S; Li W; Liu Y; Zhang J
IUBMB Life; 2021 Nov; 73(11):1378-1391. PubMed ID: 34559939
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA highly up-regulated in liver cancer promotes exosome secretion.
Cao SQ; Zheng H; Sun BC; Wang ZL; Liu T; Guo DH; Shen ZY
World J Gastroenterol; 2019 Sep; 25(35):5283-5299. PubMed ID: 31558873
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA
Zhang S; Mang Y; Li L; Ran J; Zhao Y; Li L; Gao Y; Li W; Chen G; Ma J
J Gastrointest Oncol; 2021 Dec; 12(6):3033-3049. PubMed ID: 35070428
[TBL] [Abstract][Full Text] [Related]
15. Exosomal miR-4800-3p Aggravates the Progression of Hepatocellular Carcinoma
Lin H; Peng J; Zhu T; Xiong M; Zhang R; Lei L
Front Oncol; 2022; 12():759864. PubMed ID: 35756606
[TBL] [Abstract][Full Text] [Related]
16. Exosome-mediated circTTLL5 transfer promotes hepatocellular carcinoma malignant progression through miR-136-5p/KIAA1522 axis.
Liu C; Ren C; Guo L; Yang C; Yu Q
Pathol Res Pract; 2023 Jan; 241():154276. PubMed ID: 36528986
[TBL] [Abstract][Full Text] [Related]
17. Exosome-Mediated MiR-155 Transfer Contributes to Hepatocellular Carcinoma Cell Proliferation by Targeting PTEN.
Sun JF; Zhang D; Gao CJ; Zhang YW; Dai QS
Med Sci Monit Basic Res; 2019 Oct; 25():218-228. PubMed ID: 31645540
[TBL] [Abstract][Full Text] [Related]
18. Diosgenin increased DDX3 expression in hepatocellular carcinoma.
Yu H; Liu Y; Niu C; Cheng Y
Am J Transl Res; 2018; 10(11):3590-3599. PubMed ID: 30662610
[TBL] [Abstract][Full Text] [Related]
19. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
[TBL] [Abstract][Full Text] [Related]
20. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.
Li R; Wang Y; Zhang X; Feng M; Ma J; Li J; Yang X; Fang F; Xia Q; Zhang Z; Shang M; Jiang S
Mol Cancer; 2019 Jan; 18(1):18. PubMed ID: 30704479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
